Umecrine Cognition Overview
- Founded
- 2006

- Status
- Private
- Employees
- 3

- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $2.49M

- Investors
- 5
Umecrine Cognition General Information
Description
Developer of pharmaceuticals designed to treat cognitive neurological disorders. The company's pharmaceutical products focus on finding treatments for neurological disorders in the central nervous system that are caused by endogenous CNS-active steroids (GABA-steroids), enabling healthcare industries to provide treatment that directly addresses the neurocognitive signs and symptoms of Hepatic encephalopathy.
Contact Information
- Karolinska Institutet Science Park
- Fogdevreten 2
- 171 65 Solna
- Sweden
Umecrine Cognition Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC | 04-Oct-2017 | $2.49M | 00.000 | Completed | Generating Revenue | |
2. Later Stage VC | 22-Nov-2016 | 00.000 | 00.000 | Completed | Clinical Trials - General | |
1. Early Stage VC | Completed | Startup |
Umecrine Cognition Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Magnus Doverskog Ph.D | Chief Executive Officer | ||
Torbjörn Bäckström MD | Founder & Board Member | ||
Viktor Drvota Ph.D | Chairman |
Umecrine Cognition Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Andersen Blom | Umecrine Cognition | Board Member | 000 0000 |
Bruce Scharschmidt Ph.D | Umecrine Cognition | Board Member | 000 0000 |
Kenth Bergström | Umecrine Cognition | Board Member | 000 0000 |
Thomas Blackburn Ph.D | Umecrine Cognition | Board Member | 000 0000 |
Torbjörn Bäckström MD | Umecrine Cognition | Founder & Board Member | 000 0000 |
Umecrine Cognition Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialUmecrine Cognition Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Almi Invest | Venture Capital | Minority | 000 0000 | 000000 0 | |
Fort Knox Förvaring | Holding Company | Minority | 000 0000 | 000000 0 | |
Karolinska Development | Venture Capital | Minority | 000 0000 | 000000 0 | |
Norrlandsfonden | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | |
Partnerinvest Norr | Venture Capital | Minority | 000 0000 | 000000 0 |